Search

everythinglearnresearchcommunity

for

Search:↓

More research is needed to understand chemotherapy-induced hair loss and its phases.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Iron chloride helps create compounds that could be useful in medicine, like treating hair loss.

A rigid compound with a common structural motif was successfully synthesized.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

TCDD changes skin cell growth and keratin production in mice.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Acne treatment, including isotretinoin, improves quality of life and does not worsen depression.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.